The Life Prolongation and QOL Improvement Effect of Rice Bran Arabinoxylan Derivative (MGN-3, BioBran) for Progressive Cancer

Authors: K. Takahara and K. Sano

The present study was designed to determine whether or not the administration of MGN-3 could have its apothanasia effect and improve the QOL for 205 progressive and partially nretastasized cancer patients in late III—IV stages after surgery. MGN-3 is a rice bran arabinoxylan derivative and known to have immtmomodulation activity. The participants in this clinical study are hospitalized patients in our clinic treated with complementary alternative medicines (we call it “Non-Conventional Therapy”) and anticancer medicines with lesser side effects. The 205 patients hospitalized for 6 months were grouped into two groups, viz, 109 patients (control group) treated with our standard complementary alternative medicines, and 96 patients who were further given MGN-3 (MGN-3 group) for one year and a half.

All the patients were measured for natural killer activity as an indication for the variation of immunoparameters. Simultaneously, the QOL of the patients was also checked. The NK cell activities ofthe patients alter surgery were low on average; however, by the administration of MGN-3, NK activity was observed to increase and the apothanasia ratio also increased; the higher the patient NK activity is, the higher the apothanasia ratio was observed to rise. The above Endings indicate that NK activity can be used as a pathological index of progressive cancers. QOL improvement was also observed with the administration of MGN-3.